Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

NervGen Pharma Corp. Common stock

NGEN•NASDAQ
Healthcare
Biotechnology
$3.60
$-0.27(-6.98%)
U.S. Market opens in 22h 2m

NervGen Pharma Corp. Common stock (NGEN) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for NervGen Pharma Corp. Common stock (NASDAQ:NGEN).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

NGEN Technical Analysis Summary

NervGen Pharma Corp. Common stock stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 39.57)
Trend Strength:Very Strong (ADX: 41.85)
Volatility:High (ATR: 0.28)
Support/Resistance:$3.85 – $4.39 (Bollinger Bands)

This mix signals that NervGen Pharma Corp. Common stock is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 39.57

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 22.48

Bearish
Momentum remains weak below midpoint.

Williams %R: -89.71

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -13.03

Strongly Bearish
Sharp downside momentum.

Takeaway:NervGen Pharma Corp. Common stock shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: -0.15

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 41.85

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.28

Low
Low volatility, stable price action.

CCI (14): -150.56

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:NervGen Pharma Corp. Common stock shows weakening trend signals, with bearish pressure building.

Support & Resistance indicators
Bollinger Bands
Upper Band
$4.39
Middle Band (SMA 20)
$4.12
Lower Band
$3.85
Current Position
Below Lower Band

Takeaway:NervGen Pharma Corp. Common stock trades near the lower band, signaling oversold conditions and potential rebound.

Keltner Channels
Upper Channel
$4.69
Middle Line (EMA 20)
$4.13
Lower Channel
$3.58
Squeeze Status
Squeeze On

Takeaway:NervGen Pharma Corp. Common stock trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-935.49K
Money Flow Index36.30Bearish, selling pressure outweighs inflows.
Relative Vigor Index33.11Bearish, price momentum favors sellers.

Overall Takeaway:NGEN shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of NervGen Pharma Corp. Common stock, here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:NervGen Pharma Corp. Common stock shows a Strong Sell signal — momentum, volume, and volatility confirm strong selling pressure.

Technical Analysis FAQ